Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Retinoic acid can change skin structures in vertebrates, like turning scales into feathers or hair buds into glands.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Minoxidil may promote hair growth by mimicking a natural body process.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Activating δ-opioid receptors can help hair grow.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

All four treatments for early rheumatoid arthritis had similar safety profiles.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Minoxidil sulfate relaxes muscle by increasing potassium flow, making it a unique muscle relaxer.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.